AU2006330531A1 - Use of anecortave acetate as an adjunct during filtration bleb surgery - Google Patents
Use of anecortave acetate as an adjunct during filtration bleb surgery Download PDFInfo
- Publication number
- AU2006330531A1 AU2006330531A1 AU2006330531A AU2006330531A AU2006330531A1 AU 2006330531 A1 AU2006330531 A1 AU 2006330531A1 AU 2006330531 A AU2006330531 A AU 2006330531A AU 2006330531 A AU2006330531 A AU 2006330531A AU 2006330531 A1 AU2006330531 A1 AU 2006330531A1
- Authority
- AU
- Australia
- Prior art keywords
- administration
- surgery
- iop
- glaucoma
- angiostatic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Prostheses (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75351105P | 2005-12-23 | 2005-12-23 | |
US60/753,511 | 2005-12-23 | ||
PCT/US2006/062541 WO2007076467A2 (en) | 2005-12-23 | 2006-12-22 | Use of anecortave acetate as an adjunct during filtration bleb surgery |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2006330531A1 true AU2006330531A1 (en) | 2007-07-05 |
Family
ID=38067101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2006330531A Abandoned AU2006330531A1 (en) | 2005-12-23 | 2006-12-22 | Use of anecortave acetate as an adjunct during filtration bleb surgery |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1962857A2 (ja) |
JP (1) | JP2009521511A (ja) |
KR (1) | KR20080078042A (ja) |
CN (1) | CN101346145A (ja) |
AU (1) | AU2006330531A1 (ja) |
BR (1) | BRPI0620411A2 (ja) |
CA (1) | CA2631838A1 (ja) |
WO (1) | WO2007076467A2 (ja) |
ZA (1) | ZA200805052B (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080125406A1 (en) * | 2005-10-14 | 2008-05-29 | Robin Alan L | Method for Treating Primary and Secondary Forms of Glaucoma |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5798356A (en) * | 1995-08-07 | 1998-08-25 | Alcon Laboratories, Inc. | Angiostatic compounds |
AU1970197A (en) * | 1996-05-09 | 1997-11-26 | Alcon Laboratories, Inc. | Use of steroid compounds to prevent non-cancerous tissue growth |
US6011023A (en) * | 1997-08-27 | 2000-01-04 | Alcon Laboratories, Inc. | Angiostatic steroids |
US6489305B1 (en) * | 1998-05-08 | 2002-12-03 | Canji, Inc. | Methods and compositions for the treatment of ocular diseases |
US20050239760A1 (en) * | 2004-04-23 | 2005-10-27 | Alcon, Inc. | Angiostatic agents and methods and compositions for controlling ocular hypertension |
-
2006
- 2006-12-22 CN CNA2006800489261A patent/CN101346145A/zh active Pending
- 2006-12-22 JP JP2008547781A patent/JP2009521511A/ja not_active Withdrawn
- 2006-12-22 EP EP06846780A patent/EP1962857A2/en not_active Withdrawn
- 2006-12-22 AU AU2006330531A patent/AU2006330531A1/en not_active Abandoned
- 2006-12-22 KR KR1020087016572A patent/KR20080078042A/ko not_active Application Discontinuation
- 2006-12-22 CA CA002631838A patent/CA2631838A1/en not_active Abandoned
- 2006-12-22 ZA ZA200805052A patent/ZA200805052B/xx unknown
- 2006-12-22 WO PCT/US2006/062541 patent/WO2007076467A2/en active Application Filing
- 2006-12-22 BR BRPI0620411-2A patent/BRPI0620411A2/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BRPI0620411A2 (pt) | 2011-11-08 |
WO2007076467A2 (en) | 2007-07-05 |
KR20080078042A (ko) | 2008-08-26 |
ZA200805052B (en) | 2009-10-28 |
WO2007076467A3 (en) | 2007-08-16 |
EP1962857A2 (en) | 2008-09-03 |
CA2631838A1 (en) | 2007-07-05 |
CN101346145A (zh) | 2009-01-14 |
JP2009521511A (ja) | 2009-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070197491A1 (en) | Method for treating primary and secondary forms of glaucoma | |
US20080125406A1 (en) | Method for Treating Primary and Secondary Forms of Glaucoma | |
Cunningham Jr et al. | Practical approach to the use of corticosteroids in patients with uveitis | |
US20050245497A1 (en) | Treatment of ophthalmic conditions | |
Anton et al. | Trabeculectomy ab interno with the Trabectome® as a therapeutic option for uveitic secondary glaucoma | |
Gottsch et al. | Topical cyclosporin stimulates neovascularization in resolving sterile rheumatoid central corneal ulcers. | |
JP2007056041A (ja) | 病的な眼の新脈管形成を処置するための糖質コルチコイド処方物 | |
Grzybowski et al. | Dexamethasone intraocular suspension: a long-acting therapeutic for treating inflammation associated with cataract surgery | |
EP1539182A1 (en) | Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration | |
Xu et al. | Clinical implication of triamcinolone in aqueous humor after depository sub-Tenon application | |
AU2006330531A1 (en) | Use of anecortave acetate as an adjunct during filtration bleb surgery | |
US20070043006A1 (en) | Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis | |
MX2008007884A (en) | Use of anecortave acetate as an adjunct during filtration bleb surgery | |
Agahan et al. | Intracameral Triamcinolone for the Treatment of Hyphema and Post-Surgical Iridocyclitis | |
Aswin | Outcome of glaucoma surgery in patients on prostaglandin analogues | |
CN101365456A (zh) | 治疗原发性和继发性形式的青光眼的方法 | |
Levison | Noninfectious Uveitis: Systemic and Local Corticosteroids | |
Mavrikakis et al. | Current trends of intravitreal steroid use in retinal diseases | |
Glaucoma | Glaucomas: Neovascular Glaucoma 49 | |
Markham | Submission Control No: 169671 | |
Berger | Fluocinolone Implant for Idiopathic Non-Infectious Posterior Uveitis | |
Edema | OZURDEX®(dexamethasone intravitreal implant) 0.7 mg for Treating Macular Edema Following Retinal Vein Occlusion: A Case-Based Discussion | |
Herndon | Medication-related Ocular Surface Disorders Among Glaucoma Patients | |
ZA200509532B (en) | Formulations or non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |